(1)
van de Kerkhof, P.; Pinter, A.; Boehnlein, M.; Kavanagh, S.; Crowley, J. Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2. J of Skin 2019, 3, S40.